Frazier Life Sciences
Biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics.
Frazier Life Sciences was founded in 2015, is headquartered in Palo Alto, United States, has 37 recorded investments, and includes 125 companies in its recorded portfolio.
- Headquarters
- Palo Alto, United States
- Founded
- 2015
- Website
- frazierls.com
- AUM
- $4.3B
- Portfolio Companies
- 125
- Total Investments
- 37
- Last Investment
- Jul 2026
- Geographic Focus
- United States, Europe
Indexed holds 125 portfolio companies and 37 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Frazier Life Sciences is a Venture Capital firm based in Palo Alto, United States. It was founded in 2015. It has made 37 investments, including Amunix Pharmaceuticals, Callio Therapeutics and Cidara. Focus areas include Biotech and Life Sciences.
Portfolio125
Showing 48 of 125 recorded portfolio companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 213 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×18 · Hedge Fund ×3 · Corporate VC ×2 · 66 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/frazier-life-sciences"><img src="https://indexed.vc/api/badge/investor/frazier-life-sciences" alt="Frazier Life Sciences on Indexed.vc" width="260" height="76" /></a>